Your employer may one day help determine if your genes are why your jeans have become too snug. Big companies are considering blending genetic testing with coaching on nutrition and exercise to help workers lose weight and improve their health before serious conditions like diabetes or heart disease develop.
One in three Americans has high blood pressure, a long-term constriction of arteries that can...
As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to...
Scientists have determined the 3-D structure of a key part of a protein that is associated with...
As the current Ebola outbreak wanes, scientists have to make the most of every opportunity to prepare for future outbreaks. One such opportunity involves the identification of a safe and effective Ebola vaccine. Texas supercomputers have aided researchers in modeling which types of clinical trials will provide the best information.
A concentrated extract of maple syrup makes disease-causing bacteria more susceptible to antibiotics, according to laboratory experiments by researchers at McGill Univ. The findings suggest that combining maple syrup extract with common antibiotics could increase the microbes’ susceptibility, leading to lower antibiotic usage.
Brain tumors are notoriously difficult for most drugs to reach, but Yale Univ. researchers have found a promising but unlikely new ally against brain cancers, portions of a deadly virus similar to Ebola. A virus containing proteins found in the Lassa virus not only passed through the formidable blood-brain barrier but destroyed brain tumors in mice, according to research released in the Journal of Virology.
Millions of older people are getting tests they don't need to prove they are healthy enough to have cataracts removed, a new study finds. The excess testing before this quick, ultra-safe eye procedure is costing them and Medicare a bundle, and many patients don't know they can question it, doctors say.
A newly developed spectroscopy method is helping to clarify the poorly understood molecular process by which an anti-HIV drug induces lethal mutations in the virus’ genetic material. The findings from the Univ. of Chicago and the Massachusetts Institute of Technology could bolster efforts to develop the next generation of anti-viral treatments.
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant.
A new collaborative study describes a way that lung tissue can regenerate after injury.
The discovery of antibiotics produced by soil fungi and bacteria gave the world life-saving medicine. But new antimicrobials from this resource have become scarce as the threat of drug resistance grows. Now, scientists have started mining lakes and rivers for potential pathogen-fighters, and they’ve found one from Lake Michigan that is effective against drug-resistant tuberculosis.
Yale Univ. scientists are using new chemical tools to identify and understand molecules in the human gut that alter DNA and regulate inflammatory bowel diseases and colorectal cancers. In a recent article, researchers describe the chemical structures of 32 such molecules from the bacterial colibactin pathway, found in select strains of E. coli in the gut.
Consumers are one step closer to benefiting from packaging that could give simple text warnings when food is contaminated with deadly pathogens like E. coli and Salmonella, and patients could soon receive real-time diagnoses of infections such as C. difficile right in their doctors' offices, saving critical time and trips to the lab.
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor. While standard chemotherapy drugs damage DNA to stop cancer cells from reproducing, the new method stops the source that creates those cancer cells: genes that are overexpressing certain proteins.
Scientists know that depression affects the brain, but they still don’t know why some people respond to treatment and others do not. Now UCLA researchers have shown for the first time in a large cohort of patients that electroconvulsive therapy, or ECT, changes certain areas of the brain that play a role in how people feel, learn and respond to positive and negative environmental factors.
In the 1970s, epidemiologists found that workers in factories using vinyl chloride had unusually high rates of a rare form of liver cancer called angiosarcoma. Biologists later identified a mutation that appears to be associated with this cancer, which originates in cells of the blood vessels that feed the liver.
Analyzing people’s keystrokes as they type on a computer keyboard can reveal a great deal of information about the state of their motor function, according to a new study. In the study, the researchers found that their algorithm for analyzing keystrokes could distinguish between typing done in the middle of the night, when sleep deprivation impairs motor skills, and typing performed when fully rested.
Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer’s given an experimental cancer drug, Yale School of Medicine researchers reported in the Annals of Neurology. The drug, AZD05030, developed by Astra Zeneca proved disappointing in treating solid tumors but appears to block damage triggered during the formation of amyloid-beta plaques, a hallmark of Alzheimer’s disease.
New research has identified some of the processes by which molecules associated with neurological diseases can disrupt the biological clock, interfere with sleep and activity patterns and set the stage for a spiral of health concerns that can include a decreased lifespan and Alzheimer’s disease.
Traditionally, to understand how a gene functions, a scientist would breed an organism that lacks that gene, “knocking it out”, then ask how the organism has changed. Are its senses affected? Its behavior? Can it even survive? Thanks to the recent advance of gene editing technology, this gold standard genetic experiment has become much more accessible in a wide variety of organisms.
HIV can establish itself in the brain as soon as four months after initial infection; a finding that dampens hopes of an impending cure for a disease that afflicts more than 35 million people. Within two years of infection, a genetically distinct version of HIV replicates in the brains of as many as one in four patients.
Health officials have discovered a new germ in Eastern Europe that is related to the dreaded smallpox and monkeypox viruses but so far seems far less threatening. The germ caused two cattle herders to suffer fever, swollen lymph nodes and painful boils on their hands and arms in 2013.
The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. The investments come as researchers harness recent scientific advances.
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
A pair of air pollutants linked to climate change could also be a major contributor to the unparalleled rise in the number of people sneezing and wheezing during allergy season. The gases, nitrogen dioxide and ground-level ozone, appear to provoke chemical changes in certain airborne allergens that could increase their potency. That, in combination with changes in global climate, could explain why airborne allergies are more common.
Ancient malaria patients, the anthropologist will see you now. A Yale Univ. scientist has developed a promising new method to identify malaria in the bone marrow of ancient human remains. It is the first time researchers have been able to establish a diagnostic, human skeletal profile for the disease, which is transmitted by mosquitoes and continues to infect millions of people a year.
A team of researchers in the U.K. has found a way to redesign an artificial connection between an artery and vein, known as an Arterio-Venous Fistulae, which surgeons form in the arms of people with end-stage renal disease so that those patients can receive routine dialysis, filtering their blood and keeping them alive after their kidneys fail.
Engineers at Oregon State Univ. have used additive manufacturing to create an improved type of glucose sensor for patients with Type 1diabetes, part of a system that should work better, cost less and be more comfortable for the patient. A key advance is use of electrohydrodynamic jet, or “e-jet” printing, to make the sensor.
- Page 1